Multiple Test Algorithm Okay To Support Rapid HIV Test Approval - Panel
This article was originally published in The Gray Sheet
Executive Summary
Sponsors of rapid HIV test premarket approval applications should be allowed to use a multiple test algorithm to demonstrate sensitivity and specificity performance levels for diagnostic use, FDA's Blood Products Advisory Committee recommended at a June 15 meeting in Silver Spring, Maryland.
You may also be interested in...
Epitope OraQuick On-Site HIV Test U.S. Trials Expected To Start In July
Epitope, Inc. says it will submit a premarket approval application for its OraQuick non-invasive, rapid, oral-fluid HIV-1/2 antibody test in January 2001.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.